Publicação
Phenotypic profile and molecular mechanism of resistance in carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates from Brazilian hospitals
| dc.contributor.author | Kurtz, Pedro | |
| dc.contributor.author | Del Peloso, Pedro F. | |
| dc.contributor.author | Pribul, Bruno Rocha | |
| dc.contributor.author | Albuquerque, Arthur M. | |
| dc.contributor.author | Antunes, Bianca B.P. | |
| dc.contributor.author | Ramos, Grazielle Vianna | |
| dc.contributor.author | Bozza, Fernando A. | |
| dc.contributor.institution | NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) | |
| dc.contributor.institution | Comprehensive Health Research Centre (CHRC) - pólo NMS | |
| dc.contributor.pbl | Frontiers Research Foundation | |
| dc.date.accessioned | 2026-01-14T15:52:14Z | |
| dc.date.available | 2026-01-14T15:52:14Z | |
| dc.date.issued | 2025-11 | |
| dc.description | Publisher Copyright: Copyright © 2025 Kurtz, Del Peloso, Pribul, Albuquerque, Antunes, Ramos and Bozza. | |
| dc.description.abstract | Background/Objectives: Carbapenemase-producing Enterobacterales and P. aeruginosa are critical threats to global public health, especially in high-burden regions such as Brazil. Imipenem-relebactam (IMR), a combination of a carbapenem with a β-lactamase inhibitor, is a promising treatment option against resistant Gram-negative bacteria. This study aimed to characterize phenotypic resistance and molecular mechanisms in clinical isolates from Brazilian hospitals and assess IMR activity. Methods: A prospective multicenter study was conducted across 12 hospitals in Rio de Janeiro. A total of 150 Enterobacterales and 100 P. aeruginosa isolates resistant to carbapenems were collected. Isolates were identified by MALDI-TOF and screened for carbapenemase genes (KPC, NDM, VIM, IMP, OXA-48) using PCR. Susceptibility to IMR was determined by broth microdilution following EUCAST guidelines. Next-generation sequencing (NGS) was performed on a subset of multidrug-resistant isolates. Results: IMR resistance was identified in 34.5% of K. pneumoniae and 74% of P. aeruginosa isolates. Among Enterobacterales, 21.1% of KPC-producers and 88.9% of OXA-48-producers were resistant to IMR. The bla_KPC gene was predominant, but NDM was increasingly detected. In P. aeruginosa, resistance was largely unrelated to carbapenemase production, implicating porin loss and efflux pumps. NGS revealed extensive co-resistance and multiple virulence genes in K. pneumoniae isolates. Conclusion: This study highlights the emergence of significant resistance to imipenem-relebactam in Brazil, driven by both enzymatic and non-enzymatic mechanisms. Ongoing molecular surveillance and tailored treatment strategies are essential to address the evolving threat of multidrug-resistant Gram-negative infections in endemic regions. | en |
| dc.description.version | publishersversion | |
| dc.description.version | published | |
| dc.format.extent | 280952 | |
| dc.identifier.doi | 10.3389/fmicb.2025.1689777 | |
| dc.identifier.issn | 1664-302X | |
| dc.identifier.other | PURE: 147373702 | |
| dc.identifier.other | PURE UUID: 634b0826-8a24-4e9a-a145-7befcd3487ef | |
| dc.identifier.other | Scopus: 105023680635 | |
| dc.identifier.uri | http://hdl.handle.net/10362/199003 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/105023680635 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.subject | antimicrobial therapy | |
| dc.subject | carbapenemase | |
| dc.subject | gram-negative | |
| dc.subject | imipenem-relebactam | |
| dc.subject | multi-drug resistant | |
| dc.subject | Microbiology | |
| dc.subject | Microbiology (medical) | |
| dc.subject | SDG 3 - Good Health and Well-being | |
| dc.title | Phenotypic profile and molecular mechanism of resistance in carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates from Brazilian hospitals | en |
| dc.title.subtitle | implications for the introduction of imipenem-relebactam | en |
| dc.type | journal article | |
| degois.publication.title | Frontiers in Microbiology | |
| degois.publication.volume | 16 | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess |
Ficheiros
Principais
1 - 1 de 1
A carregar...
- Nome:
- fmicb-16-1689777.pdf
- Tamanho:
- 274.37 KB
- Formato:
- Adobe Portable Document Format
